LV5806B4 - LHL antagonisti - Google Patents

LHL antagonisti

Info

Publication number
LV5806B4
LV5806B4 LV960307A LV960307A LV5806B4 LV 5806 B4 LV5806 B4 LV 5806B4 LV 960307 A LV960307 A LV 960307A LV 960307 A LV960307 A LV 960307A LV 5806 B4 LV5806 B4 LV 5806B4
Authority
LV
Latvia
Prior art keywords
lhl
antagonist
lhl antagonist
Prior art date
Application number
LV960307A
Other languages
English (en)
Other versions
LV5806A4 (lv
Inventor
Tamas Janaky
Atilla Juhasz
Andrew Schally
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of LV5806A4 publication Critical patent/LV5806A4/lv
Publication of LV5806B4 publication Critical patent/LV5806B4/lv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/11—Gonadotropin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/32—Modification to prevent enzymatic degradation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
LV960307A 1991-01-30 1996-07-22 LHL antagonisti LV5806B4 (lv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/647,786 US5171835A (en) 1988-10-21 1991-01-30 LHRH antagonists

Publications (2)

Publication Number Publication Date
LV5806A4 LV5806A4 (lv) 1997-02-20
LV5806B4 true LV5806B4 (lv) 1997-06-20

Family

ID=24598270

Family Applications (1)

Application Number Title Priority Date Filing Date
LV960307A LV5806B4 (lv) 1991-01-30 1996-07-22 LHL antagonisti

Country Status (13)

Country Link
US (1) US5171835A (lv)
EP (1) EP0522152A1 (lv)
JP (1) JPH05505630A (lv)
CA (1) CA2079461A1 (lv)
FI (1) FI924405A0 (lv)
HU (1) HUT63635A (lv)
IE (1) IE920287A1 (lv)
LV (1) LV5806B4 (lv)
MX (1) MX9200342A (lv)
PT (1) PT100077B (lv)
TW (1) TW304198B (lv)
WO (1) WO1992013883A1 (lv)
ZA (1) ZA92600B (lv)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6429186B1 (en) 1991-05-10 2002-08-06 Genentech, Inc. Ligand antagonists for treatment of breast cancer
TW333456B (en) * 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
DK0683792T3 (da) * 1992-12-18 2002-01-14 Abbott Lab LHRH-antagonister med modificerede aminoacylrester i stilling 5 og 6
JP3795914B2 (ja) * 1993-04-27 2006-07-12 ユナイテッド・バイオメディカル・インコーポレイテッド ワクチン用免疫原性ｌｈｒｈペプチド構築体および合成普遍免疫刺激器
US5759551A (en) * 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
US5413990A (en) * 1993-08-06 1995-05-09 Tap Pharmaceuticals Inc. N-terminus modified analogs of LHRH
US5502035A (en) * 1993-08-06 1996-03-26 Tap Holdings Inc. N-terminus modified analogs of LHRH
DE4342091A1 (de) * 1993-12-09 1995-06-14 Asta Medica Ag Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten
US6048863A (en) 1994-04-19 2000-04-11 Takeda Chemical Industries, Ltd. Condensed-ring thiophene derivatives and thienopyrimidine derivatives, their production and use
AP775A (en) * 1994-07-22 1999-10-28 The Eastern Virginia Medical School Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens.
US5843901A (en) 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
CA2229201A1 (en) * 1995-10-19 1997-04-24 Satoshi Sasaki Quinoline derivatives, their production and use
WO1997014697A1 (en) * 1995-10-19 1997-04-24 Takeda Chemical Industries, Ltd. Thienopyridine derivatives as gonadotropin releasing hormone antagonists
US5828149A (en) * 1996-07-18 1998-10-27 Baker Hughes Incorported Lubricant inducer pump for electrical motor
US5968895A (en) 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US5925730A (en) 1997-04-11 1999-07-20 Ferring Bv GnRH antagonists
US5821230A (en) * 1997-04-11 1998-10-13 Ferring Bv GnRH antagonist decapeptides
US6217844B1 (en) 1998-04-27 2001-04-17 Praecis Pharmaceuticals, Inc. Methods for detecting lesions in dense breast tissue using LHRH antagonists
FR2788527A1 (fr) * 1999-01-15 2000-07-21 Bio Merieux Pseudopeptide, procede de synthese, reactif et applications
US6455499B1 (en) 1999-02-23 2002-09-24 Indiana University Foundation Methods for treating disorders associated with LHRH activity
AU7627200A (en) * 1999-07-29 2001-02-19 Johns Hopkins University, The Activation of peptide prodrugs by hk2
EP1297850B1 (en) * 2000-07-05 2015-08-19 Takeda Pharmaceutical Company Limited Medicinal preparations for treating sex hormone-dependent diseases
US6583153B2 (en) 2000-12-12 2003-06-24 Ortho-Mcneil Pharmaceutical, Inc. 7-heterocyclyl quinoline and thieno[2,3-b]yridine derivatives useful as antagonists of gonadotropin releasing hormone
US6598784B2 (en) * 2000-12-20 2003-07-29 Meadwestvaco Packaging Syatens, Llc Beverage carton with strap type carrying handle
WO2002056903A2 (en) * 2001-01-17 2002-07-25 Praecis Pharmaceuticals Inc. Methods for treating hormone associated conditions using a combination of lhrh antagonists and specific estrogen receptor modulators
WO2003064429A1 (fr) 2002-01-30 2003-08-07 Takeda Chemical Industries, Ltd. Thienopyrimidines, procedes de fabrication et d'utilisation correspondants
WO2005067889A1 (en) 2003-12-30 2005-07-28 Durect Corporation Polymeric implants, preferably containing a mixture of peg and plg, for controlled release of active agents, preferably a gnrh
US20110171191A1 (en) 2008-06-12 2011-07-14 Syntaxin Limited Suppression of neuroendocrine diseases
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
ES2747839T3 (es) 2013-10-30 2020-03-11 Shanghai hengrui pharmaceutical co ltd Derivados de pirazolopirimidona o de pirrolotriazona, método de preparación de los mismos, y aplicaciones farmacéuticas de los mismos
WO2021018105A1 (en) 2019-07-29 2021-02-04 Sunshine Lake Pharma Co., Ltd. Substituted pyrimidinedione compounds and uses thereof
WO2023072284A1 (zh) 2021-11-01 2023-05-04 山东绿叶制药有限公司 促性腺素释放激素拮抗剂及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3963691A (en) * 1974-10-07 1976-06-15 Merck & Co., Inc. Synthetic antigens of luteinizing hormone releasing hormone
FI832053L (fi) * 1982-06-10 1983-12-11 Syntex Inc Nonapeptid- och dekapeptidanaloger av lhrh anvaendbara som lhrh-antagonister samt deras framstaellningsfoerfarande
US4565804A (en) * 1984-09-07 1986-01-21 The Salk Institute For Biological Studies GnRH Antagonists VI
US4851385A (en) * 1987-07-15 1989-07-25 Indiana University Foundation LHRH antagonist analogs having low histamine-release activity
US4800191A (en) * 1987-07-17 1989-01-24 Schally Andrew Victor LHRH antagonists
US4935491A (en) * 1987-08-24 1990-06-19 Board Of Regents, The University Of Texas System Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine
EP0364819A3 (en) * 1988-10-21 1991-03-06 The Administrators of The Tulane Educational Fund Lhrh analogs
GB2228262B (en) * 1989-01-25 1992-10-07 Nat Inst Immunology Antigenic derivative of gnrh
NL8900726A (nl) * 1989-03-23 1990-10-16 Stichting Centr Diergeneeskund Peptide, immunogene samenstelling en vaccin- of geneesmiddelpreparaat; werkwijze voor het immuniseren van een zoogdier tegen lhrh, en werkwijze voor het verbeteren van de vleeskwaliteit van varkens.

Also Published As

Publication number Publication date
ZA92600B (en) 1992-10-28
PT100077A (pt) 1993-04-30
HU9202778D0 (en) 1992-12-28
TW304198B (lv) 1997-05-01
PT100077B (pt) 1999-06-30
EP0522152A1 (en) 1993-01-13
JPH05505630A (ja) 1993-08-19
FI924405A (fi) 1992-09-30
IE920287A1 (en) 1992-07-29
LV5806A4 (lv) 1997-02-20
MX9200342A (es) 1992-08-01
HUT63635A (en) 1993-09-28
FI924405A0 (fi) 1992-09-30
US5171835A (en) 1992-12-15
WO1992013883A1 (en) 1992-08-20
CA2079461A1 (en) 1992-07-31

Similar Documents

Publication Publication Date Title
LV5806B4 (lv) LHL antagonisti
FI925387A0 (fi) Soekarrangemang i centralsystem foer cellulaer mobiltelefoni
FI930855A (fi) Tillaempningarnas modularitet i datakommunikationscentraler
FI933594A0 (fi) Kanalbenaemningsapparat foer en televisionsmottagare
FI933855A (fi) Kontinuerlig blandningsmaskin uppdelad i sektioner
FI932245A (fi) Faskombinationsfoerfarande och -anordning foer anvaendning i en flerantennmottagare
FI931661A0 (fi) Inhalationsanordning
NO303785B1 (no) Boreslamadditiv
FI921435A (fi) Skydd foer saenkpump i svaora foerhaollanden
FI922759A (fi) Loesningsmedelskompositioner foer anvaendning i tryckkaensligt kopieringspapper
FI923724A (fi) Monterings- och distansanordning foer braenslestavarna i en kokvattenreaktor
FI933553A (fi) Foerbaettrad ingaong foer lastbils lastutrymmes vaegg
FI925206A (fi) Rengoerningsprodukt i vaetskeform
FI935507A (fi) Foerbaettring i en lyftbommekanism
FI935566A (fi) Insertionsmutationer i mycobakterier
FI924750A (fi) Zirkoniumbaserad legering foer komponenter i kaernreaktorer
FI922180A (fi) Tuggummi innehaollande tuggummibas i en valsningsblandning
FI935280A0 (fi) Dihydroxiindanontyrosinkinasinhibitorer
FI923438A (fi) Enfasig loesnings- och kausticeringsmetod
FI923608A (fi) Vaetskeavlaegsningssystem foer vaermevaexlare
NO920045D0 (no) Vannbaaret nitrocelluloselakkemulsjon
FI930938A (fi) Vaetskekompositioner innehaollande komplexa karboxylestrar
FI920998A (fi) Skaermad hytt i modulkonstruktion
TR25953A (tr) SüBSTITüE EDILMIS 2-ARILPIROLLER
NO305649B1 (no) Silot°mmeanordning